Literature DB >> 21523646

Fatal complication after thrombin injection for post-catheterization femoral pseudoaneurysm.

R Gabrielli1, M S Rosati, S Vitale, M Millarelli, R Chiappa, A Siani, L Irace, G Caselli.   

Abstract

Femoral artery pseudoaneurysm (FAP) is one of the most common vascular complications after cardiac and peripheral angiographic procedures. Ultrasound-guided thrombin injection is the standard procedure for the treatment of FAP. Complications such as thrombotic events with leg ischemia after thrombin leakage into the femoral artery or immunogenic consequences are rare. Our experience indicates the need for caution when treating FAP, as severe complications can occur after thrombin injection in a femoral pseudoaneurysm, leading to a fatal event. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21523646     DOI: 10.1055/s-0030-1270837

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  4 in total

1.  Novel Technique to Treat Common Femoral Artery Pseudoaneurysm using Angio-Seal Closure Device.

Authors:  Jon Robken; Nicolas W Shammas
Journal:  Int J Angiol       Date:  2014-07-04

2.  Novel interventional technique for the treatment of an iatrogenic pseudoaneurysm of the brachial artery.

Authors:  Yusuke Inagaki; Masashi Nakao; Hiroyuki Arashi; Junichi Yamaguchi
Journal:  J Cardiol Cases       Date:  2021-11-20

3.  Percutaneous Thrombin Injection Based on Computational Fluid Dynamics of Femoral Artery Pseudoaneurysms.

Authors:  Hyoung-Ho Kim; Kyung-Wuk Kim; Changje Lee; Young Ho Choi; Min Uk Kim; Yasutaka Baba
Journal:  Korean J Radiol       Date:  2021-07-26       Impact factor: 3.500

4.  Ultrasound-guided thrombin injection in the management of pseudoaneurysm after percutaneous arterial access.

Authors:  Tomasz Jargiełło; Jan Sobstyl; Łukasz Światłowski; Maryla Kuczyńska; Ewa Kuklik; Michał Sojka; Anna Drelich-Zbroja; Maciej Pech; Maciej Powerski
Journal:  J Ultrason       Date:  2018
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.